Ask AI
ProCE Banner Activity

Actionable AI in Cardiology: Addressing Current Limitations and Future Directions

Clinical Thought

The 2024 JACC state-of-the-art review lays out a detailed framework for developing actionable artificial intelligence (AI) for real-world cardiology practice. Learn what the experts are saying and how their experiences are further reinforcing the future directions of AI argued in the review.

Released: October 28, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

Program Director Disclosure

Program Director

Evangelos K. Oikonoumou, MD, DPhil

Assistant Professor
Section of Cardiovascular Medicine
Department of Internal Medicine
Yale School of Medicine
New Haven, Connecticut

Evangelos K. Oikonomou, MD, DPhil: royalties or patent beneficiary: Caristo Diagnostics Ltd; consultant: Ensight-AI Inc.

Faculty Disclosure

Primary Author

Pierre Elias, MD: researcher: Edwards, Janssen, Pfizer; consultant/advisor/speaker: GE.

Sammy Elmariah, MD, MPH: researcher: Abbott, Medtronic.

Francisco Lopez-Jimenez, MD, MSc, MBA: consultant/advisor/speaker: Anumana, Mediwhale, Novo Nordisk.

Louise Sun, MD, SM, FRCPC, FAHA, has no relevant financial relationships to disclose.